Cromos Pharma

Call Directions Website

Cromos Pharma Cromos Pharma is an international research organization (CRO) specializing in clinical trials. Find out more by visiting www.cromospharma.com.

Established in 2004, Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 15 years' experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe. Its US base is in Portland, Oregon with additional operations in South Florida and its European HQ is situated in Dublin, Ireland.

AI can support clinical trial decisions. But who is accountable when something goes wrong?As AI becomes increasingly int...
10/19/2026

AI can support clinical trial decisions. But who is accountable when something goes wrong?

As AI becomes increasingly integrated into clinical research, questions around validation, human oversight, risk management, and accountability are more important than ever.

We asked Joris De Maeseneire, Head of Quality at Cromos Pharma, six key questions about AI governance, evolving FDA and EMA expectations, and what it takes to ensure responsible AI use in clinical trials.

The key takeaway? You can delegate the task. You cannot delegate the accountability.

Read the full interview: https://cromospharma.com/ai-quality-and-accountability-six-questions-every-quality-leader-should-ask/

10/15/2026

Cromos Pharma is currently seeking an In-house Clinical Research Associate (CRA) to join our team.

Location: Europe

For additional details about this opportunity, please visit our website: https://cromospharma.com/in-house-cra/

If you're ready to apply, please send your CV to [email protected]

10/13/2026

We are pleased to share that Vlad Bogin, MD, FACP, CEO of Cromos Pharma, will be attending ESMO Congress 2026, taking place from October 23 to 27 in Madrid, Spain.

As one of the world’s leading oncology events, ESMO brings together the global oncology community to share the latest advances in cancer research, treatment, and clinical development. Vlad looks forward to connecting with industry leaders and discussing how Cromos Pharma’s oncology expertise and tailored clinical trial solutions can support sponsors in advancing their development programs.

To connect with Vlad during ESMO 2026 or to learn more about how Cromos Pharma can support your oncology clinical development needs, contact us at [email protected].

Biopharma innovation is accelerating. But is clinical development keeping pace?From rising R&D costs and longer developm...
10/08/2026

Biopharma innovation is accelerating. But is clinical development keeping pace?

From rising R&D costs and longer development timelines to the growing role of emerging biotech and AI, the pharmaceutical industry is facing a new set of challenges.

In our latest article, we explore 7 key numbers shaping biopharma R&D in 2026 and what they mean for sponsors navigating an increasingly complex clinical development landscape.

Discover the trends behind the numbers and why clinical ex*****on is becoming just as critical as scientific innovation.

Read the full article: https://cromospharma.com/state-of-biopharma-r-d-2026-7-numbers-every-sponsor-should-know/

In the latest edition of Cromos Pharma’s Newsletter, we highlight key developments shaping clinical research and healthc...
10/06/2026

In the latest edition of Cromos Pharma’s Newsletter, we highlight key developments shaping clinical research and healthcare innovation:

- Replimune secures accelerated FDA approval for Tudriqev after two previous rejections.
- A gene-edited pig kidney keeps a patient off dialysis for a record 271 days.
- Beacon Therapeutics reports positive results from the first successful pivotal gene therapy trial for X-linked retinitis pigmentosa.

Read the full Newsletter: https://cromospharma.com/clinical-research-focus-57th-edition/

10/02/2026

Cromos Pharma is currently seeking a Head of Project Management to join our team.

Location: Europe or USA

For additional details about this opportunity, please visit our website: https://lnkd.in/e3dJPvvP

If you're ready to apply, please send your CV to [email protected]

New Patient Education Videos Are Now AvailableWe’ve added new videos to our patient education library, answering some of...
09/30/2026

New Patient Education Videos Are Now Available

We’ve added new videos to our patient education library, answering some of the most common questions patients may have before and during clinical trial participation.

- Who can see your medical data in a clinical trial?
- Does a placebo always mean no treatment?
- Can you leave a clinical trial after joining?
- What support may be available for patients and their families?
- What does a typical day in a clinical trial look like?

Our short videos explain these topics in clear, simple language, helping patients and their families better understand what clinical trial participation involves.

Watch the latest videos here: https://cromospharma.com/patients-portal/explainer-videos-for-patients/

Patient education is only one piece of the puzzle. Through our AV Department, Cromos Pharma also develops study-specific explainer videos, patient-facing websites, and digital recruitment campaigns that have supported enrollment efforts across oncology, rare disease, CNS, cardiovascular, and other therapeutic areas.

Better-informed patients. Better engagement. Better recruitment.

The obesity drug race is entering a new phase.Eli Lilly and Novo Nordisk have set a high bar, but competition is acceler...
09/29/2026

The obesity drug race is entering a new phase.

Eli Lilly and Novo Nordisk have set a high bar, but competition is accelerating with oral therapies, next generation incretins, amylin based drugs, and new approaches to efficacy and convenience.

Who could challenge today’s market leaders?

Read our latest article to explore the companies and clinical programs shaping the future of obesity treatment.

Read more: https://cromospharma.com/the-obesity-drug-race-who-can-challenge-lilly-and-novo/

09/22/2026

We are pleased to share that Vlad Bogin, MD, FACP, CEO of Cromos Pharma, will be attending ESMO Congress 2026, taking place from October 23 to 27 in Madrid, Spain.

As one of the world’s leading oncology events, ESMO brings together the global oncology community to share the latest advances in cancer research, treatment, and clinical development. Vlad looks forward to connecting with industry leaders and discussing how Cromos Pharma’s oncology expertise and tailored clinical trial solutions can support sponsors in advancing their development programs.

To connect with Vlad during ESMO 2026 or to learn more about how Cromos Pharma can support your oncology clinical development needs, contact us at [email protected].


Best,

Address

US Bancorp Tower, 111 S. W. Fifth Avenue, Suite 3150
Portland, OR
97204

Alerts

Be the first to know and let us send you an email when Cromos Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share